GoodRx Holdings, Inc. - Common Stock (GDRX)

Q3 2020 13F Holders as of 30 Sep 2020

Type / Class
Equity / Common Stock
Shares outstanding
98,685,316
Total 13F shares
36,809,881
Share change
+36,775,693
Total reported value
$2,047,016,218
Put/Call ratio
472%
Price per share
$55.60
Number of holders
141
Value change
+$2,045,139,230
Number of buys
138

Institutional Holders of GoodRx Holdings, Inc. - Common Stock (GDRX) as of Q3 2020

As of 30 Sep 2020, GoodRx Holdings, Inc. - Common Stock (GDRX) was held by 141 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 36,809,881 shares. The largest 10 holders included Silver Lake Group, L.L.C., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, LIGHT STREET CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, BAMCO INC /NY/, Capital International Investors, TIGER GLOBAL MANAGEMENT LLC, and Capital World Investors. This page lists 142 institutional shareholders reporting positions in this security for the Q3 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.